Toward gene therapy for disorders of globin synthesis

This publication has 69 references indexed in Scilit:

• Development of lentiviral vectors for gene therapy for human diseases
  Blood, 2000
• Cytokine Prestimulation as a Gene Therapy Strategy: Implications for Using the MDR1 Gene as a Dominant Selectable Marker
  Blood, 1997
• Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA ⁻ Immunodeficient Patients
  Science, 1995
• Multiple elements in human β-globin locus control region 5′ HS 2 are involved in enhancer activity and position independent, transgene expression
  Nucleic Acids Research, 1994
• Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
  The Lancet, 1993
• Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells
  Blood, 1993
• Development of Gene Therapy for Immunodeficiency: Adenosine Deaminase Deficiency
  Pediatric Research, 1993
• Altering the Genome by Homologous Recombination
  Science, 1989
• A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells.
  Molecular and Cellular Biology, 1989
• The β-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner
  Cell, 1989